Galenica falls on plans to shut down unit's pharma production

Galenica AG

24/02/2026 09:36

** Galenica GALE.S falls ~7% to 94.6 Swiss francs, a more than six-week low; set for worst day since June 2022

** Stock falls to bottom of Switzerland's mid-cap index .SMIM

** Healthcare company's subsidiary Bichsel intends to discontinue pharmaceutical production by year end

** Co says consultation process initiated; adds up to 170 jobs will be affected

** Expects one-off special costs of 35 mln-40 mln Swiss francs ($45.23 mln-$51.69 mln) in H1 FY26

** YTD, GALE down 2.7%

($1 = 0.7738 Swiss francs)

 (Reporting by Ozan Ergenay)

 ((ozan.ergenay@thomsonreuters.com))